Skip to content

Pain relief during childbirth

Evaluation of analgesic effect of pudendal nerve block in second stage of labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008598
Enrollment
110
Registered
2017-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Healthy antenatal women

Interventions

Intervention1: 5 ml 1% Lignocaine,5 ml of 0.25% bupivacaine: Pudendal nerve block (transvaginal)-combination of above mentioned drugs given bilaterally in second stage of labor. Control Intervention1:

Sponsors

Vardhman Mahavir Medical College and Safdarjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primigravida women at term pregnancy with vertex presentation who were in active phase of labor and without any complications.

Exclusion criteria

Exclusion criteria: Women with cervical dilatation Ë? 6 cm, multiple pregnancy, cephalopelvic disproportion, pregnancy induced hypertension, moderate and severe anemia, heart disease, other medical and surgical illness, known allergy to any of the drugs to be used and who were not willing to participate in the study.

Design outcomes

Primary

MeasureTime frame
Pain relief in second stage of laborTimepoint: From beginning of second stage (full dilatation of cervix), till delivery of the baby.

Secondary

MeasureTime frame
Duration of second stage of laborTimepoint: ---;Fetal outcomeTimepoint: Apgar score at 0 minute and 5 minutes;Maternal complicationsTimepoint: Laceration, hematoma

Countries

India

Contacts

Public ContactShweta Mittal

V.M.M.C. and Safdarjung Hospital

banashree_a@yahoo.com9810184280

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026